The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
So taking in to account that long COVID is a remarkable risk the approach should be not via lungs but vascular way from the very beginning ? Just as a thought
My erased thought in short was that in case an other IFN B will get approved maybe big Pharma companies get interested about Faron’s Traumakine and maybe not only about Traumakine but the whole company and Bex.
..and not speaking about Faron interviews.
…or was my interpretation of some past interviews there…?
Thanks Sax, very good! I think I am on the map better now. Out there on the other place some scenarios were askel and I gave my best, but I was erased despite being positive on their behalf too just like you and seeing the benefits for all IFNB even though each has their own route to go. Maybe my bragging on behalf of Faron and Bex was too much among other ideas.
Thanks Sax, I agree the company is building up value and that’s what Markku has been saying. From outside it’s not always possible to see it happening. It’s like a ship in a shipyard constantly adding value ever since from the table of the designers and while work in a progress it’s been engineered and modified to get the best possible outcome. And for most of the people the value becomes real when the ship is in the water and taking the cargo to the destinations. So it’s a long project/process There in between many things can happen and engineer can have joy but also sleepless night many times but they’ll fight to find ways to win the challenges. There in between maybe some instances might have been interested to buy the project. But buyers might have withdrawn from it for what ever reason to buy “only” a 47 feet long yacht or nothing at all. What can you say with an NDA. We can only speculate.
“Being able to target the right patients is the key to even better data .And it looks like they are making superb progress in that area.” Sax I borrow your phrasing into an other context namely referring it to the other there. Do you know are those others being dosed with steroids or is it random there? Haven’t read their clinical trial plans do you know is there any mentioning about steroids? Is it compared to placebo? If so are equal proportions of steroids used? If compared to steroids only then a clear case to see when their P3 results lands?
“I just hope one of my other shares pops before then , and I can move a bit more in here .“
Sax what do you think about that corticosteroids are a problem here but not there? Is it because we have the focus on a bit later phase concerning the severity of the disease?
Great company mastering IFNB and IFNG! Where will this all end up!
The message is clear at the moment - focusing on Bex!
At least as a business but think them as disciplined but creative scientists. Is it possible that these tree programs are lining up in an unbelievable way around cancer, organ protection and bone marrow being more than a sum of its parts. All programs supporting each other at some point. Some value cooking up we don’t see but they see.
All economies are stressed and the current situation of world’s economics is chaotic and unbearable. Better to have some stress here and there otherwise you need to show that actually we can’t solve the crisis of the financial system.
In a miniature Russia is in a situation than they need to have a war anyway or they have to face the situation of the nation.
Not saying we shouldn’t need to cope with pandemics. And we are in a good way anyway. A new vaccine can be designed in a day against new variants. And it is in a days or weeks in production. Safety and tolerability needs some testing and no need for P3. That’s how it goes. And in addition to that these many treatment coming out.
“Every chance is an opportunity “ said the opposite counterpart of the Eddy the Eagle.
An other nasal spray drug (preclinical, got patented in US) also against COVID under development containing aprotinin, hydroxychloroquine and invermectin. And not only against COVID-19. It is thought to prevent the virus to grip the cell surface, prevent the virus get out from the cell through the endosomal layer and preventing transporting virus proteins in to the nucleus. Surprisingly these many times harmful recognized drug substances are trying to prove their safety and efficacy in a new setup and in small concentrations.
In case beta better antiviral than alpha against COVID why not to make similar Heberon like substance out of beta? Somebody has the manufacturing patent for Inerferon Beta in powder form?
“They got the idea from Heberon. The drug that has been used in Russia and Cuba for the last 3 decades.
Interferon alpha 2 beta mixed in to a solution which can either be sprayed intranasal or used as eye drops.”
Just wondering why Faron Pharmaceuticals Ltd. (AIM: FARN) is not taking the advantage because they have the manufacturing patent in hands to produce IV intravenous formula of Inf Beta. As far as I understand the output is a powder form Inf Beta that will be dissolved to be used in Intravenous administering on sites for hospitalized patients.
Maybe it is not that simple as been in Cuba? Not complaining, but it’s different with FDA.
Wonderful Hold4r,
Very touching and I feel it’s very intimate song for you. I liked it too. Maybe I have to reveal myself. Here we go
https://youtu.be/Qf_HoB6RRKI
I am almost there, some would say I am.
Meant “…check out anytime…”
Thanks Hold4r,
Was nice to watch.
Listen to that
https://youtu.be/EqPtz5qN7HM
Could be a song for every bb.
“You can check anytime you like but you can never leave “ Fits us all!
Thanks Hanoi!
Thanks Mutting!
Scenarios asked Part Iii
I truly hope P3 will pass the finale well and soon.
I am not sure if people like to inhale stuff in their lungs. It’s the most sensitive organ I feel. I had asthma and used Salbuvent for almost twenty years. Ever since I started ice swimming it disappeared. I hated to inhale it but now after next twenty years I do not think I have got any damage from it either. But I hated it, even though it helped me.
I am not saying that Pfizer’s Paxlovid COVID pill would be easier to accept as a treatment. Especially it needs to be accepted in a very early phase when one still unsure of the symptoms.
But now there is a new tester to tell you the diagnosis very fast. This can be a game changer on behalf of Pfizer or Synairgen too in case SNG home dosing gets approved.
Deep Sensing Algorithms Ltd (DSA) has completed the development of the world’s first ultra-rapid COVID-19 detection technology. The DSA BreathPass™ solution, which provides a result in less than a minute, now carries the EU wide medical CE certification and is available for deliveries….and the rest will be history I think.
(from a press release in 14th of Jan)
“Finnish medical device company Deep Sensing Algorithms Ltd (DSA) has completed the development of the world’s first ultra-rapid COVID-19 detection technology. The DSA BreathPass™ solution, which provides a result in less than a minute, now carries the EU wide medical CE certification and is available for deliveries.
DSA BreathPass™ is a portable, handheld device that analyses exhaled breath to detect COVID-19 infection. The human defense mechanisms start immediately after the infection and the metabolic byproducts of the person’s immune response start to appear in exhaled breath within the same day.
The product is simple to use – an individual simply breathes once into the device, and an algorithm provides a result after the measuring period of 45 seconds. The device can be ready for the next individual in 2 minutes.
The solution is intended for detecting COVID-19 infection in both asymptomatic and pre-symptomatic people. Due to the early warning nature of the COVID-19 detection, it is suited for screening applications where healthy feeling and asymptomatic people wish to receive assurance of their condition. “
….would that fit well with Synairgen’s at home administration plans?
Cwebb, I welcome these presentations very informative, we are kept updated regardless of if anything new at all. The latest presentations haven’t got much buzz around the share anyhow, maybe the responsibility to judge the value of the business is left for the listeners.
Partnering news would change the situation because then some ransom and landmarks would cast the value in pure money. At the same time of course we can say good buy to alternative choices. But if so then better believe in it as the best choice compared to any other negotiable agreement.
Is it more like R&D day in the 27th?